Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

STD Testing Devices Market Size

ID: MRFR/HC/7110-HCR
90 Pages
Vikita Thakur
Last Updated: April 06, 2026

STD Testing Devices Market Research Report By Type of Test (Serological Tests, Molecular Tests, Rapid Tests, Nucleic Acid Amplification Tests), By End User (Hospitals, Diagnostic Laboratories, Home Care Settings, Public Health Organizations), By Product Type (Test Kits, Equipment, Consumables), By Application (Chlamydia Testing, Gonorrhea Testing, Syphilis Testing, HIV Testing, Hepatitis Testing) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

STD Testing Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Std Testing Devices Size

STD Testing Devices Market Growth Projections and Opportunities

The market for STD testing devices is influenced by increasing public health awareness about sexually transmitted diseases (STDs). Educational campaigns and initiatives aimed at promoting regular testing contribute to a growing demand for convenient and accessible testing devices. The growing prevalence of STDs across the world is one of the major factors which is fostering the STD medications market. The need for fast and accurate tests increases dramatically due to falling demand thus prompting the market growth. This trend of testing at home that is on the rise in both instances now also applies to STD testing. The advantages of the home testing devices like convenience and privacy attract market those customers who want to test STD in the peaceful environment and hence, become an additional driver of the market for the home testing devices. Technological progress has resulted in the manufacture of better STD testing gadgets which are more effective and convenient to use. Innovations in the form of RDTs, molecular diagnostics as well as smartphone based testing solutions facilitate higher accuracy of tests coupled with accessibility hence influencing the demand and market size. Government programs and public health initiatives dedicated to the very purpose of controlling the spread of STDs are also the market dynamics. Supported testing, awareness campaign, and free distribution of testing kits to some areas promote usage and lead market advancement. The high-risk sexual behaviors, greater awareness among MSM and people of multi-sex partners regarding regular testing, thus advocate the need for STD testing devices, tailored to match specific risk factors, in the market. The STD testing equipment integration with telemedicine and e-health systems improves accessibility and extends the scope of testing provision. The market is driven by remote consultations, test result delivery, and follow-up care, which are some of the increasing digitalization health care services have. This also needs to be done promptly and accurately because of development of antibiotic resistant strains of STDs such as gonorrhoea. In the face of dynamic patterns of emerging disease, testing gadgets that can fast pinpoint particular strains and prescribe functional remedies turn out to be increasingly beneficial. The infection of STDs across borders is mainly increased by globalization and traveling between borders. As people require testing tools that are portable and easy to operate in traveling or in different geographical areas, chances of demand increasing grow.

The inclusion of STD testing in corporate wellness programs is becoming more prevalent as employers recognize the importance of employee health. This trend contributes to the market by creating a demand for workplace-friendly testing solutions and promoting regular screening.

STD Testing Devices Market Size Graph
Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the STD Testing Devices Market by 2035?

<p>The STD Testing Devices Market is projected to reach a valuation of 12.01 USD Billion by 2035.</p>

What was the market valuation of the STD Testing Devices Market in 2024?

<p>In 2024, the overall market valuation was 7.111 USD Billion.</p>

What is the expected CAGR for the STD Testing Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the STD Testing Devices Market during the forecast period 2025 - 2035 is 4.88%.</p>

Which segment is anticipated to have the highest valuation in the STD Testing Devices Market by 2035?

<p>By 2035, the 'Test Kits' segment is anticipated to reach a valuation of 4.2 USD Billion.</p>

What are the key players in the STD Testing Devices Market?

<p>Key players in the market include Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific, among others.</p>

How did the valuation of Molecular Tests change from 2024 to 2035?

<p>The valuation of Molecular Tests increased from 2.0 USD Billion in 2024 to a projected 3.5 USD Billion by 2035.</p>

What is the projected valuation for the Home Care Settings segment by 2035?

<p>The Home Care Settings segment is projected to reach a valuation of 2.5 USD Billion by 2035.</p>

Which application segment is expected to grow the most by 2035?

<p>The HIV Testing application segment is expected to grow the most, reaching a valuation of 4.0 USD Billion by 2035.</p>

What was the valuation of Rapid Tests in 2024?

<p>In 2024, the valuation of Rapid Tests was 1.8 USD Billion.</p>

How does the valuation of Diagnostic Laboratories compare to that of Hospitals by 2035?

<p>By 2035, the valuation of Hospitals is expected to be 4.0 USD Billion, compared to 3.0 USD Billion for Diagnostic Laboratories.</p>

Market Summary

As per Market Research Future analysis, the STD Testing Devices Market was estimated at 7.111 USD Billion in 2024. The STD Testing Devices industry is projected to grow from 7.458 USD Billion in 2025 to 12.01 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 4.88% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The STD Testing Devices Market is experiencing a transformative shift towards home testing and digital integration.

  • The rise of home testing kits is reshaping consumer access to STD testing, particularly in North America. Integration of digital health solutions is enhancing the efficiency and accuracy of STD diagnostics across various platforms. Molecular tests remain the largest segment, while rapid tests are emerging as the fastest-growing category in the market. Increased awareness of STDs and technological advancements in testing devices are driving growth, especially in hospitals and diagnostic laboratories.

Market Size & Forecast

2024 Market Size 7.111 (USD Billion)
2035 Market Size 12.01 (USD Billion)
CAGR (2025 - 2035) 4.88%
Largest Regional Market Share in 2024 North America

Major Players

Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Hologic, Inc. (US), BD (Becton, Dickinson and Company) (US), Siemens Healthineers (DE), Cepheid (US), <a href="https://www.bio-rad.com/en-in/category/sexually-transmitted-diseases?ID=ND3K2MKSY">Bio-Rad Laboratories</a> (US), Orasure Technologies, Inc. (US)

Market Trends

The STD Testing Devices Market is currently experiencing a notable transformation, driven by advancements in technology and increasing awareness regarding sexually transmitted diseases. The proliferation of home testing kits appears to be reshaping consumer behavior, as individuals seek more convenient and private options for testing. This shift may lead to a broader acceptance of regular testing, potentially reducing the stigma associated with sexually transmitted infections.

Furthermore, the integration of digital health solutions, such as mobile applications and telemedicine, seems to enhance accessibility and encourage proactive health management among diverse populations. In addition, the STD Testing Devices Market is likely influenced by ongoing public health initiatives aimed at promoting sexual health education. These efforts may foster a more informed public, leading to increased demand for testing devices.

Moreover, the emergence of innovative diagnostic technologies, including rapid tests and point-of-care devices, could significantly improve the speed and accuracy of results. As the market evolves, stakeholders must remain vigilant to adapt to changing consumer preferences and technological advancements, ensuring that they meet the needs of a diverse and dynamic population.

Rise of Home Testing Kits

The growing preference for home testing kits indicates a shift towards convenience and privacy in the STD Testing Devices Market. Consumers are increasingly inclined to utilize these kits, which allow for discreet testing in the comfort of their own homes, thereby reducing barriers to access.

Integration of Digital Health Solutions

The incorporation of digital health technologies, such as mobile applications and telehealth services, appears to enhance the accessibility of STD testing. These solutions may facilitate easier appointment scheduling, result tracking, and educational resources, promoting proactive health management.

Innovative Diagnostic Technologies

The introduction of advanced diagnostic tools, including rapid tests and point-of-care devices, suggests a potential transformation in the STD Testing Devices Market. These innovations may lead to quicker and more accurate results, thereby improving patient outcomes and encouraging regular testing.

STD Testing Devices Market Market Drivers

Rising Incidence of STDs

The increasing incidence of STDs is a primary driver of the STD Testing Devices Market. Recent epidemiological studies indicate a concerning rise in infections, particularly among younger populations. This trend has prompted health authorities to emphasize the importance of regular testing as a preventive measure. As more individuals become aware of their STD status, the demand for testing devices is expected to escalate. The STD Testing Devices Market is likely to benefit from this growing need, as healthcare providers and consumers alike recognize the critical role of testing in managing and controlling the spread of STDs.

Increased Awareness of STDs

The heightened awareness surrounding sexually transmitted diseases (STDs) has catalyzed growth in the STD Testing Devices Market. Educational campaigns and public health initiatives have played a pivotal role in informing individuals about the risks associated with STDs. This awareness has led to a surge in demand for testing devices, as individuals seek to take proactive measures regarding their sexual health. According to recent data, the prevalence of STDs has been on the rise, prompting health organizations to advocate for regular testing. Consequently, the STD Testing Devices Market is experiencing a notable uptick in sales, as consumers prioritize their health and well-being.

Government Initiatives and Funding

Government initiatives aimed at combating STDs are significantly influencing the STD Testing Devices Market. Various health departments are allocating funds to improve testing accessibility and affordability. These initiatives often include subsidized testing programs and the distribution of free testing kits in high-risk populations. Such efforts not only enhance public health outcomes but also stimulate demand for testing devices. Recent statistics indicate that regions with robust government support for STD testing have witnessed a marked increase in testing rates. This trend suggests that continued government involvement will be crucial for the sustained growth of the STD Testing Devices Market.

Shift Towards Preventive Healthcare

The shift towards preventive healthcare is reshaping the STD Testing Devices Market. As individuals increasingly prioritize preventive measures over reactive treatments, the demand for testing devices is on the rise. This trend is supported by a growing body of evidence linking early detection of STDs to better health outcomes. Health professionals are advocating for routine testing, particularly in sexually active populations. Consequently, the STD Testing Devices Market is witnessing a surge in interest from both consumers and healthcare providers. This proactive approach to health management is likely to sustain market growth in the coming years.

Technological Advancements in Testing Devices

Technological innovations are transforming the landscape of the STD Testing Devices Market. The introduction of rapid testing kits and point-of-care testing solutions has made it easier for individuals to access testing. These advancements not only enhance the accuracy of results but also reduce the time required for diagnosis. For instance, the development of molecular testing technologies has improved the sensitivity and specificity of STD tests. As a result, healthcare providers are increasingly adopting these advanced devices, contributing to the overall growth of the STD Testing Devices Market. The integration of technology into testing processes is likely to continue driving market expansion.

Market Segment Insights

By Type: Molecular Tests (Largest) vs. Rapid Tests (Fastest-Growing)

<p>The STD Testing Devices Market is characterized by a diverse range of testing methodologies, with Molecular Tests dominating the segment. This category is recognized for its accuracy and effectiveness in detecting sexually transmitted infections (STIs). In contrast, Rapid Tests are gaining significant traction due to their user-friendly nature and quick results, making them increasingly popular among both healthcare providers and patients. As health awareness rises, the share of each testing type continues to evolve, reflecting changing preferences and advancements in technology. Growth trends within the STD testing realm indicate a robust expansion trajectory for both Molecular Tests and Rapid Tests. The demand for faster, more reliable testing methods is steering innovation in the market. Moreover, growing public awareness and proactive healthcare initiatives contribute to the increased adoption of these testing methods, underscoring a shift towards efficient and comprehensive health solutions.</p>

<p>Molecular Tests (Dominant) vs. Serological Tests (Emerging)</p>

<p>Molecular Tests have positioned themselves as the leading choice within the STD Testing Devices Market, primarily due to their high sensitivity and specificity in identifying infections at various stages. These tests utilize advanced technologies, allowing for precise results and the ability to detect low viral loads, which is crucial for timely diagnosis and treatment. Meanwhile, Serological Tests are emerging as an alternative option, particularly in community settings where access to advanced technology may be limited. While generally more cost-effective and simpler to administer, Serological Tests provide valuable insights, especially in screening asymptomatic populations for early detection. As the landscape evolves, both testing types offer unique advantages that cater to different patient needs.</p>

By End User: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

<p>In the STD Testing Devices Market, hospitals represent the largest end user segment, driven by the high volume of patients seeking testing and treatment for STDs. They offer comprehensive services, including on-site testing and treatment, contributing significantly to their market share. Meanwhile, diagnostic laboratories are quickly emerging as the fastest-growing segment, due to their specialized testing capabilities and the rising demand for precise and timely results, which enhances patient care and accelerates diagnosis.</p>

<p>Healthcare Sector: Hospitals (Dominant) vs. Public Health Organizations (Emerging)</p>

<p>Hospitals play a dominant role in the STD Testing Devices Market due to their extensive infrastructure, access to technology, and ability to provide immediate care and follow-up. They are equipped with advanced diagnostic devices and serve a wide patient base, leading to increased testing rates. Conversely, public health organizations are emerging as vital players, primarily focusing on preventive measures, education, and outreach programs. They leverage community resources to enhance awareness and accessibility to testing, thus driving growth in this segment. Their efforts are crucial in addressing the stigma surrounding STDs, making testing more approachable and increasing overall market participation.</p>

By Product Type: Test Kits (Largest) vs. Equipment (Fastest-Growing)

<p>In the STD Testing Devices Market, product type segmentation reveals that Test Kits dominate the landscape, holding a substantial share due to their convenience and high demand for at-home testing solutions. Equipment, while currently smaller in market share, is emerging rapidly, driven by technological advancements and a growing focus on point-of-care testing capabilities. The steady demand for reliable and accurate testing options continues to bolster both segments, making them crucial to the market's overall dynamics. The growth trends for these segments indicate a significant shift towards more user-friendly and accessible testing alternatives. Test Kits benefit from increased awareness and sensitivity surrounding STDs, encouraging more individuals to seek testing. Meanwhile, Equipment segments are witnessing exponential growth as healthcare providers invest in modernizing their facilities and optimizing testing processes, indicative of a long-term transformation in STD diagnostic practices.</p>

<p>Test Kits (Dominant) vs. Equipment (Emerging)</p>

<p>Test Kits play a dominant role in the STD Testing Devices Market due to their ease of use and ability to facilitate private and convenient testing options. The rise of at-home testing kits has expanded accessibility, catering to individuals who prefer discretion. This segment is characterized by rapid innovation, with manufacturers focusing on developing more accurate and user-friendly kits. In contrast, Equipment remains an emerging segment, showcasing the latest advancements in technology for onsite testing. Typically utilized in clinical settings, this category includes automated analyzers and diagnostic tools that promise efficiency and high throughput. The demand for these sophisticated tools is projected to increase as healthcare institutions prioritize enhanced testing capabilities, illustrating the dual trajectory of growth within the market.</p>

By Application: HIV Testing (Largest) vs. Chlamydia Testing (Fastest-Growing)

<p>Within the STD Testing Devices Market, HIV Testing holds the largest share, reflecting its prioritization in healthcare due to the critical nature of early detection in managing the disease. Following this, Chlamydia Testing is emerging as a significant player, with an increasing number of testing initiatives being implemented worldwide, emphasizing the need for regular screenings among different demographics.</p>

<p>Testing Methods: HIV Testing (Dominant) vs. Chlamydia Testing (Emerging)</p>

<p>HIV Testing is characterized by its established protocols and widespread availability across healthcare settings, making it the dominant method in the market. This method has gained traction due to robust awareness programs that promote early diagnosis as a prevention strategy. On the other hand, Chlamydia Testing is rapidly gaining ground, with innovative approaches like home testing kits and point-of-care devices. These advancements cater to the growing demand for convenient and accessible testing options, particularly among younger populations. As awareness about STDs increases, Chlamydia Testing is positioned to expand significantly, attracting investments and research initiatives.</p>

Get more detailed insights about STD Testing Devices Market Research Report - Forecast till 2035

Regional Insights

North America : Leading Market for Innovation

North America is the largest market for STD testing devices, holding approximately 45% of the global market share. The region's growth is driven by increasing awareness of sexually transmitted diseases, advancements in diagnostic technologies, and supportive government regulations. The demand for rapid and accurate testing solutions is on the rise, fueled by initiatives aimed at improving public health outcomes and reducing the stigma associated with STDs. The United States is the primary contributor to this market, with significant investments in healthcare infrastructure and research. Key players such as Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific dominate the landscape, offering a range of innovative testing solutions. The competitive environment is characterized by continuous product development and strategic partnerships, ensuring that North America remains at the forefront of STD testing technology.

Europe : Regulatory Framework Enhances Growth

Europe is the second-largest market for STD testing devices, accounting for approximately 30% of the global market share. The region benefits from stringent regulatory frameworks that promote the adoption of advanced diagnostic technologies. Increased funding for public health initiatives and rising awareness of STDs among the population are key drivers of market growth. Countries like Germany and the UK are leading the charge, with a focus on improving testing accessibility and accuracy. Germany, the UK, and France are the leading countries in this market, supported by a robust healthcare system and a high prevalence of testing programs. Major players such as Siemens Healthineers and Hologic, Inc. are actively involved in developing innovative solutions tailored to meet regional needs. The competitive landscape is marked by collaborations between public health organizations and private companies, enhancing the overall effectiveness of STD testing in Europe.

Asia-Pacific : Emerging Market with High Potential

Asia-Pacific is an emerging powerhouse in the STD testing devices market, holding about 20% of the global market share. The region's growth is driven by increasing healthcare expenditure, rising awareness of STDs, and government initiatives aimed at improving sexual health. Countries like China and India are witnessing a surge in demand for testing devices, supported by efforts to combat the rising rates of STIs and promote preventive healthcare measures. China and India are the leading countries in this market, with significant investments in healthcare infrastructure and public health campaigns. The competitive landscape is evolving, with both local and international players striving to capture market share. Companies like Cepheid and Bio-Rad Laboratories are expanding their presence in the region, focusing on innovative testing solutions that cater to the unique needs of the population. The market is expected to grow rapidly as awareness and accessibility improve.

Middle East and Africa : Untapped Market with Challenges

The Middle East and Africa represent a resource-rich frontier in the STD testing devices market, holding approximately 5% of the global market share. The region faces unique challenges, including limited healthcare infrastructure and cultural stigmas surrounding STDs. However, increasing government initiatives aimed at improving public health and rising awareness of sexually transmitted infections are driving demand for testing devices. Countries like South Africa and Nigeria are at the forefront of these efforts, working to enhance testing accessibility. South Africa is the leading country in this market, supported by various public health campaigns and partnerships with international organizations. The competitive landscape is characterized by a mix of local and global players, with companies like Orasure Technologies, Inc. making strides in the region. As awareness grows and healthcare systems improve, the market is poised for significant growth in the coming years.

Key Players and Competitive Insights

The STD Testing Devices Market has witnessed significant growth due to increasing awareness about sexually transmitted diseases, advancements in technology, and governmental initiatives aimed at promoting sexual health. The competitive landscape of this market is characterized by the presence of several key players who are continuously innovating and enhancing their product offerings to meet the growing demand for efficient and accurate testing solutions. Competitive insights reveal that companies are focusing on differentiating their products by incorporating advanced technologies such as point-of-care testing, automation, and integrated software solutions.
Strategic collaborations and partnerships among various stakeholders, including healthcare providers, research organizations, and technological firms, have been pivotal in expanding market reach and improving service delivery. Furthermore, the shift towards personalized healthcare and telemedicine has driven companies to develop user-friendly and accessible testing devices catering to a wider consumer base. Siemens Healthineers stands out in the STD Testing Devices Market owing to its robust portfolio of innovative diagnostic solutions that enhance the accuracy and reliability of testing.
The company has made significant investments in research and development, facilitating the creation of advanced testing platforms that can detect multiple sexually transmitted infections with a single test. The strength of Siemens Healthineers lies in its strong global presence and established relationships with healthcare providers, enabling widespread distribution and accessibility of its devices. Their commitment to integrating digital solutions with traditional testing methods enhances operational efficiency, thus promoting effective disease management.
The company's ability to adapt to changing market dynamics and address specific health challenges by offering tailored solutions sets it apart from its competitors, solidifying its leadership position in the STD testing landscape. Acon Laboratories has carved a niche in the STD Testing Devices Market through its focus on rapid and efficient testing solutions. The company leverages its expertise in lateral flow technology to deliver products that provide quick results, catering to the growing demand for fast and accurate diagnostics in various settings, including clinics and at-home testing.
Acon Laboratories' strengths lie in its commitment to quality assurance and adherence to regulatory standards, ensuring that its devices consistently meet the necessary health requirements. The company's emphasis on user-centric design has made it a preferred choice for patients and healthcare providers alike, as its testing kits are intuitive and easy to use. Additionally, Acon Laboratories actively seeks to expand its product range and enhance its offerings by incorporating feedback from healthcare professionals and consumers, positioning itself as a responsive player ready to meet the evolving needs of the market.

Key Companies in the STD Testing Devices Market include

Industry Developments

Recent developments in the STD Testing Devices Market have indicated significant growth, driven by increased awareness and demand for early detection of sexually transmitted diseases. Companies like Siemens Healthineers and Thermo Fisher Scientific are advancing their product lines to include more accurate and rapid testing options. Acon Laboratories and BioRad Laboratories are also focusing on innovative technologies to improve the efficiency of testing processes. Notably, Roche Holding, through its subsidiary F. Hoffmann-La Roche, has made strides in research and development to enhance testing accuracy.

Current affairs reflect a competitive landscape, with Hologic and Cepheid expanding their market reach and investing in partnerships to bolster their product offerings. Additionally, Abbott Laboratories has reported growth in market valuation due to new product launches and strategic marketing initiatives. In terms of mergers and acquisitions, OraSure Technologies and BD are actively pursuing collaborative opportunities to enhance their market presence. There is a growing shift towards integrated testing devices that combine various STI tests, aiming to streamline diagnosis and improve patient outcomes.

This trend signifies a robust interest in enhancing the overall capacity and capability within the STD testing devices market.

Future Outlook

STD Testing Devices Market Future Outlook

The STD Testing Devices Market is projected to grow at a 4.88% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising demand for rapid testing solutions.

New opportunities lie in:

  • Development of mobile testing units for remote areas
  • Integration of AI for predictive analytics in testing
  • Expansion of subscription-based testing services for regular monitoring

By 2035, the market is expected to be robust, driven by innovation and increased accessibility.

Market Segmentation

STD Testing Devices Market Type Outlook

  • Serological Tests
  • Molecular Tests
  • Rapid Tests
  • Nucleic Acid Amplification Tests

STD Testing Devices Market End User Outlook

  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Public Health Organizations

STD Testing Devices Market Application Outlook

  • Chlamydia Testing
  • Gonorrhea Testing
  • Syphilis Testing
  • HIV Testing
  • Hepatitis Testing

STD Testing Devices Market Product Type Outlook

  • Test Kits
  • Equipment
  • Consumables

Report Scope

MARKET SIZE 2024 7.111(USD Billion)
MARKET SIZE 2025 7.458(USD Billion)
MARKET SIZE 2035 12.01(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 4.88% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott Laboratories (US), Roche Diagnostics (CH), Thermo Fisher Scientific (US), Hologic, Inc. (US), BD (Becton, Dickinson and Company) (US), Siemens Healthineers (DE), Cepheid (US), Bio-Rad Laboratories (US), Orasure Technologies, Inc. (US)
Segments Covered Type of Test, End User, Product Type, Application, Regional
Key Market Opportunities Integration of telehealth solutions enhances accessibility in the STD Testing Devices Market.
Key Market Dynamics Rising consumer awareness drives demand for innovative STD testing devices amid evolving regulatory standards.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the STD Testing Devices Market by 2035?

<p>The STD Testing Devices Market is projected to reach a valuation of 12.01 USD Billion by 2035.</p>

What was the market valuation of the STD Testing Devices Market in 2024?

<p>In 2024, the overall market valuation was 7.111 USD Billion.</p>

What is the expected CAGR for the STD Testing Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the STD Testing Devices Market during the forecast period 2025 - 2035 is 4.88%.</p>

Which segment is anticipated to have the highest valuation in the STD Testing Devices Market by 2035?

<p>By 2035, the 'Test Kits' segment is anticipated to reach a valuation of 4.2 USD Billion.</p>

What are the key players in the STD Testing Devices Market?

<p>Key players in the market include Abbott Laboratories, Roche Diagnostics, and Thermo Fisher Scientific, among others.</p>

How did the valuation of Molecular Tests change from 2024 to 2035?

<p>The valuation of Molecular Tests increased from 2.0 USD Billion in 2024 to a projected 3.5 USD Billion by 2035.</p>

What is the projected valuation for the Home Care Settings segment by 2035?

<p>The Home Care Settings segment is projected to reach a valuation of 2.5 USD Billion by 2035.</p>

Which application segment is expected to grow the most by 2035?

<p>The HIV Testing application segment is expected to grow the most, reaching a valuation of 4.0 USD Billion by 2035.</p>

What was the valuation of Rapid Tests in 2024?

<p>In 2024, the valuation of Rapid Tests was 1.8 USD Billion.</p>

How does the valuation of Diagnostic Laboratories compare to that of Hospitals by 2035?

<p>By 2035, the valuation of Hospitals is expected to be 4.0 USD Billion, compared to 3.0 USD Billion for Diagnostic Laboratories.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Type (USD Billion)
    2. | | 4.1.1 Serological Tests
    3. | | 4.1.2 Molecular Tests
    4. | | 4.1.3 Rapid Tests
    5. | | 4.1.4 Nucleic Acid Amplification Tests
    6. | 4.2 Healthcare, BY End User (USD Billion)
    7. | | 4.2.1 Hospitals
    8. | | 4.2.2 Diagnostic Laboratories
    9. | | 4.2.3 Home Care Settings
    10. | | 4.2.4 Public Health Organizations
    11. | 4.3 Healthcare, BY Product Type (USD Billion)
    12. | | 4.3.1 Test Kits
    13. | | 4.3.2 Equipment
    14. | | 4.3.3 Consumables
    15. | 4.4 Healthcare, BY Application (USD Billion)
    16. | | 4.4.1 Chlamydia Testing
    17. | | 4.4.2 Gonorrhea Testing
    18. | | 4.4.3 Syphilis Testing
    19. | | 4.4.4 HIV Testing
    20. | | 4.4.5 Hepatitis Testing
    21. | 4.5 Healthcare, BY Region (USD Billion)
    22. | | 4.5.1 North America
    23. | | | 4.5.1.1 US
    24. | | | 4.5.1.2 Canada
    25. | | 4.5.2 Europe
    26. | | | 4.5.2.1 Germany
    27. | | | 4.5.2.2 UK
    28. | | | 4.5.2.3 France
    29. | | | 4.5.2.4 Russia
    30. | | | 4.5.2.5 Italy
    31. | | | 4.5.2.6 Spain
    32. | | | 4.5.2.7 Rest of Europe
    33. | | 4.5.3 APAC
    34. | | | 4.5.3.1 China
    35. | | | 4.5.3.2 India
    36. | | | 4.5.3.3 Japan
    37. | | | 4.5.3.4 South Korea
    38. | | | 4.5.3.5 Malaysia
    39. | | | 4.5.3.6 Thailand
    40. | | | 4.5.3.7 Indonesia
    41. | | | 4.5.3.8 Rest of APAC
    42. | | 4.5.4 South America
    43. | | | 4.5.4.1 Brazil
    44. | | | 4.5.4.2 Mexico
    45. | | | 4.5.4.3 Argentina
    46. | | | 4.5.4.4 Rest of South America
    47. | | 4.5.5 MEA
    48. | | | 4.5.5.1 GCC Countries
    49. | | | 4.5.5.2 South Africa
    50. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott Laboratories (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Roche Diagnostics (CH)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Thermo Fisher Scientific (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Hologic, Inc. (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 BD (Becton, Dickinson and Company) (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Siemens Healthineers (DE)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 Cepheid (US)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Bio-Rad Laboratories (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Orasure Technologies, Inc. (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TYPE
    4. | 6.4 US MARKET ANALYSIS BY END USER
    5. | 6.5 US MARKET ANALYSIS BY PRODUCT TYPE
    6. | 6.6 US MARKET ANALYSIS BY APPLICATION
    7. | 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY END USER
    9. | 6.9 CANADA MARKET ANALYSIS BY PRODUCT TYPE
    10. | 6.10 CANADA MARKET ANALYSIS BY APPLICATION
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY END USER
    14. | 6.14 GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    15. | 6.15 GERMANY MARKET ANALYSIS BY APPLICATION
    16. | 6.16 UK MARKET ANALYSIS BY TYPE
    17. | 6.17 UK MARKET ANALYSIS BY END USER
    18. | 6.18 UK MARKET ANALYSIS BY PRODUCT TYPE
    19. | 6.19 UK MARKET ANALYSIS BY APPLICATION
    20. | 6.20 FRANCE MARKET ANALYSIS BY TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY END USER
    22. | 6.22 FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    23. | 6.23 FRANCE MARKET ANALYSIS BY APPLICATION
    24. | 6.24 RUSSIA MARKET ANALYSIS BY TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY END USER
    26. | 6.26 RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    27. | 6.27 RUSSIA MARKET ANALYSIS BY APPLICATION
    28. | 6.28 ITALY MARKET ANALYSIS BY TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY END USER
    30. | 6.30 ITALY MARKET ANALYSIS BY PRODUCT TYPE
    31. | 6.31 ITALY MARKET ANALYSIS BY APPLICATION
    32. | 6.32 SPAIN MARKET ANALYSIS BY TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY END USER
    34. | 6.34 SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    35. | 6.35 SPAIN MARKET ANALYSIS BY APPLICATION
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY END USER
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY END USER
    43. | 6.43 CHINA MARKET ANALYSIS BY PRODUCT TYPE
    44. | 6.44 CHINA MARKET ANALYSIS BY APPLICATION
    45. | 6.45 INDIA MARKET ANALYSIS BY TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY END USER
    47. | 6.47 INDIA MARKET ANALYSIS BY PRODUCT TYPE
    48. | 6.48 INDIA MARKET ANALYSIS BY APPLICATION
    49. | 6.49 JAPAN MARKET ANALYSIS BY TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY END USER
    51. | 6.51 JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    52. | 6.52 JAPAN MARKET ANALYSIS BY APPLICATION
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY END USER
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY END USER
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY APPLICATION
    61. | 6.61 THAILAND MARKET ANALYSIS BY TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY END USER
    63. | 6.63 THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    64. | 6.64 THAILAND MARKET ANALYSIS BY APPLICATION
    65. | 6.65 INDONESIA MARKET ANALYSIS BY TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY END USER
    67. | 6.67 INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    68. | 6.68 INDONESIA MARKET ANALYSIS BY APPLICATION
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY END USER
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY APPLICATION
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY END USER
    76. | 6.76 BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    77. | 6.77 BRAZIL MARKET ANALYSIS BY APPLICATION
    78. | 6.78 MEXICO MARKET ANALYSIS BY TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY END USER
    80. | 6.80 MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    81. | 6.81 MEXICO MARKET ANALYSIS BY APPLICATION
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY END USER
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY APPLICATION
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY END USER
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY END USER
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY END USER
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY APPLICATION
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY END USER, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY END USER, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY APPLICATION, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY END USER, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY APPLICATION, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY END USER, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY APPLICATION, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY END USER, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY APPLICATION, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY END USER, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY APPLICATION, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY END USER, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY APPLICATION, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY END USER, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY APPLICATION, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY END USER, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY APPLICATION, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY END USER, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY APPLICATION, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY END USER, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY APPLICATION, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY END USER, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY APPLICATION, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY END USER, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY APPLICATION, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY END USER, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY APPLICATION, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY END USER, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY APPLICATION, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY END USER, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY APPLICATION, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY END USER, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY APPLICATION, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY END USER, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY APPLICATION, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY END USER, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY APPLICATION, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY END USER, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY APPLICATION, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY END USER, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY APPLICATION, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY END USER, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY APPLICATION, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY END USER, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY APPLICATION, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY END USER, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY APPLICATION, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY END USER, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY APPLICATION, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY END USER, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY APPLICATION, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY END USER, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY APPLICATION, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY END USER, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY APPLICATION, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY END USER, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY APPLICATION, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY END USER, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY PRODUCT TYPE, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY APPLICATION, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Serological Tests
  • Molecular Tests
  • Rapid Tests
  • Nucleic Acid Amplification Tests

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Home Care Settings
  • Public Health Organizations

Healthcare By Product Type (USD Billion, 2025-2035)

  • Test Kits
  • Equipment
  • Consumables

Healthcare By Application (USD Billion, 2025-2035)

  • Chlamydia Testing
  • Gonorrhea Testing
  • Syphilis Testing
  • HIV Testing
  • Hepatitis Testing
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓